These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 6392146)

  • 1. Detection of herpes simplex virus induced polypeptides in rabbit trigeminal ganglia.
    Green MT; Dunkel EC; Courtney RJ
    Invest Ophthalmol Vis Sci; 1984 Dec; 25(12):1436-40. PubMed ID: 6392146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immediate early and early polypeptides in herpesvirus latency.
    Rajcáni J; Matis J
    Acta Virol; 1981 Nov; 25(6):371-5. PubMed ID: 6120638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of HSV-1 infection in trigeminal ganglion cells. An in vitro model of latency.
    Dunkel EC; Green MT; Rosborough JP
    Invest Ophthalmol Vis Sci; 1984 May; 25(5):525-33. PubMed ID: 6325365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of herpes simplex virus mRNA in latently infected trigeminal ganglion neurons by in situ hybridization.
    Tenser RB; Dawson M; Ressel SJ; Dunstan ME
    Ann Neurol; 1982 Mar; 11(3):285-91. PubMed ID: 6284019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of an immediate early herpes simplex virus type 1 polypeptide in trigeminal ganglia from latently infected animals.
    Green MT; Courtney RJ; Dunkel EC
    Infect Immun; 1981 Dec; 34(3):987-92. PubMed ID: 7037648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Herpes simplex virus type 1 latency-associated transcript expression protects trigeminal ganglion neurons from apoptosis.
    Branco FJ; Fraser NW
    J Virol; 2005 Jul; 79(14):9019-25. PubMed ID: 15994795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T lymphocytes in the trigeminal ganglia of rabbits during corneal HSV infection.
    Gebhardt BM; Hill JM
    Invest Ophthalmol Vis Sci; 1988 Nov; 29(11):1683-91. PubMed ID: 3263346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative studies on activation of latent herpes simplex virus in rabbits.
    Kocisová M; Rajcáni J; Szántó J
    Acta Virol; 1985 Sep; 29(5):373-85. PubMed ID: 2866691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severity of experimentally reactivated herpetic eye disease is related to the neurovirulence of the latent virus.
    Stroop WG; Schaefer DC
    Invest Ophthalmol Vis Sci; 1987 Feb; 28(2):229-37. PubMed ID: 8591901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Herpes simplex virus recovery in neural tissues after ocular HSV shedding induced by epinephrine iontophoresis to the rabbit cornea.
    Hill JM; Kwon BS; Shimomura Y; Colborn GL; Yaghmai F; Gangarosa LP
    Invest Ophthalmol Vis Sci; 1983 Feb; 24(2):243-7. PubMed ID: 6298139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of immediate early protein ICP27/IE63 and thymidine kinase in the course of reactivation of latent herpes simplex virus 1 infection.
    Durmanová V; Rajcáni J
    Acta Virol; 2003; 47(3):159-65. PubMed ID: 14658844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HSV-1 quantitation from rabbit neural tissues after epinephrine-induced reactivation.
    Shimomura Y; Dudley JB; Gangarosa LP; Hill JM
    Invest Ophthalmol Vis Sci; 1985 Jan; 26(1):121-5. PubMed ID: 2981786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Herpes simplex virus type 1 latency in the murine nervous system is associated with oxidative damage to neurons.
    Valyi-Nagy T; Olson SJ; Valyi-Nagy K; Montine TJ; Dermody TS
    Virology; 2000 Dec; 278(2):309-21. PubMed ID: 11118355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuronal control of herpes simplex virus latency.
    Tenser RB; Edris WA; Hay KA
    Virology; 1993 Aug; 195(2):337-47. PubMed ID: 8393231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Herpes simplex virus and malignancies of female genital organs].
    Cokić-Damjanović J; Horvat E; Balog A
    Med Pregl; 2001; 54(9-10):432-7. PubMed ID: 11876004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Herpes simplex virus type 1 envelope subunit vaccine not only protects against lethal virus challenge, but also may restrict latency and virus reactivation.
    Rajcáni J; Sabó A; Mucha V; Kostál M; Compel P
    Acta Virol; 1995 Feb; 39(1):37-49. PubMed ID: 7572468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Innate and acquired immunity to herpes simplex virus type 1.
    Halford WP; Veress LA; Gebhardt BM; Carr DJ
    Virology; 1997 Sep; 236(2):328-37. PubMed ID: 9325240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the hypothalamic pituitary adrenal axis and IL-6 in stress-induced reactivation of latent herpes simplex virus type 1.
    Noisakran S; Halford WP; Veress L; Carr DJ
    J Immunol; 1998 Jun; 160(11):5441-7. PubMed ID: 9605146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methods for detecting the HSV-1 LAT anti-apoptosis activity in virus infected tissue culture cells.
    Jin L; Perng GC; Brick DJ; Naito J; Nesburn AB; Jones C; Wechsler SL
    J Virol Methods; 2004 Jun; 118(1):9-13. PubMed ID: 15158063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intradermal doxorubicin reduces ganglionic reactivation of latent herpes simplex virus in mice after pretreatment with hypertonic saline.
    Sekizawa T; Openshaw H; Itoyama Y
    J Med Virol; 2003 Jun; 70(2):263-6. PubMed ID: 12696114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.